Melatonin protects against chromium (VI) induced hepatic oxidative stress and toxicity: Duration dependent study with realistic dosage

Author:

Banerjee Sudip1,Joshi Niraj1,Mukherjee Raktim1,Singh Prem Kumar1,Baxi Darshee1,Ramachandran A.V.1

Affiliation:

1. Department of Zoology, Faculty of Science , The Maharaja Sayajirao University of Baroda , Sayajigunj, Vadodara – 390 002 , India

Abstract

Abstract The present study was undertaken to assess the degree of oxidative stress and toxic effects induced by chromium on hepatic tissue in male Wistar rats exposed to a realistic dosage of Cr(VI) (20 mg/kg/b.w./day) through drinking water, based on the levels of these metals found in the environment, for a duration of 15, 30 and 60 days. The protective effect of melatonin (10 mg/kg) was also studied by simultaneous administration with the metal. Levels of enzymatic and non-enzymatic antioxidants as well as lipid peroxidation were assessed. There was a significant decrease in enzymatic as well as non-enzymatic antioxidants and an increase in the lipid peroxidation level, which were prevented and maintained at near-normal levels by the administration of melatonin in all treatment periods. Metal accumulation was maximal at 15 days, with gradual decreases till 60 days. Histopathological observations also demonstrated the fact that Cr (VI) exposure leads to cytological lesions in the hepatic tissue promoting cellular necrotic/apoptotic changes, while melatonin was able to counteract insults induced by Cr (VI) at all treatment periods. It also prevented alterations in insulin and glucose levels. Overall, the present study suggests a duration-dependent effect of Cr on hepatic oxidative stress and cytotoxicity and shows the potent activity of melatonin in preventing the negative effects of Cr (VI).

Publisher

Walter de Gruyter GmbH

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology

Reference57 articles.

1. Anand SS. (2005). Pyridoxine attenuates chromium-induced oxidative stress in rat kidney. Basic Clin Pharmacol Toxicol97: 58–60.10.1111/j.1742-7843.2005.pto_97109.x

2. Anderson RA. (1986). Chromium metabolism and its role in disease process in man. Clin. Physiol. Biochem.4: 31–41.

3. Anderson RA. (1993). Recent advances in the clinical and biochemical effects of chromium deficiency. In: Essential and toxic trace elements in human health and disease: an update. New York, Wiley-Liss, Inc. pp. 221–234.

4. Arivarasu NA, Fatima S, Mahmood R. (2008) Oral administration of potassium dichromate inhibits brush border membrane enzymes and alters anti-oxidant status of rat intestine. Arch Toxicol82:951–8.

5. Bagchi D, Bagchi M, Stohs SJ. (2001).Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene. Molecular and Cellular Biochemistry222:149–58.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3